WO1994001136A1 - A drug delivery device and a method of making such device - Google Patents
A drug delivery device and a method of making such device Download PDFInfo
- Publication number
- WO1994001136A1 WO1994001136A1 PCT/DK1993/000227 DK9300227W WO9401136A1 WO 1994001136 A1 WO1994001136 A1 WO 1994001136A1 DK 9300227 W DK9300227 W DK 9300227W WO 9401136 A1 WO9401136 A1 WO 9401136A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cross
- drug
- polymer
- matrix
- delivery device
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL93307050A PL172724B1 (en) | 1992-07-07 | 1993-07-06 | Therapeutic system and method of obtaining same |
CA002139747A CA2139747A1 (en) | 1992-07-07 | 1993-07-06 | A drug delivery device and a method of making such device |
JP6502843A JPH07508735A (en) | 1992-07-07 | 1993-07-06 | Drug delivery device and method for manufacturing the device |
BR9306700A BR9306700A (en) | 1992-07-07 | 1993-07-06 | A drug delivery device and a process for producing that device |
RU95105519A RU2139093C1 (en) | 1992-07-07 | 1993-07-06 | Medicinal agent delivery device and method of its manufacture |
EP93914649A EP0648129A1 (en) | 1992-07-07 | 1993-07-06 | A drug delivery device and a method of making such device |
SK17-95A SK1795A3 (en) | 1992-07-07 | 1993-07-06 | Drug delivery device and method of this production |
AU44178/93A AU671651B2 (en) | 1992-07-07 | 1993-07-06 | A drug delivery device and a method of making such device |
KR1019950700048A KR950702437A (en) | 1992-07-07 | 1993-07-06 | A DRUG DELIVERY DEVICE AND A METHOD OF MAKING SUCH DEVICE |
FI950065A FI950065A (en) | 1992-07-07 | 1995-01-05 | A device for administering a medicament and a method of making such a device |
NO950072A NO950072L (en) | 1992-07-07 | 1995-01-06 | Drug delivery device and method of preparation thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK0895/92 | 1992-07-07 | ||
DK92895A DK89592D0 (en) | 1992-07-07 | 1992-07-07 | PHARMACEUTICAL DELIVERY ESTABLISHMENT AND PROCEDURES FOR PREPARING THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994001136A1 true WO1994001136A1 (en) | 1994-01-20 |
Family
ID=8098759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1993/000227 WO1994001136A1 (en) | 1992-07-07 | 1993-07-06 | A drug delivery device and a method of making such device |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0648129A1 (en) |
JP (1) | JPH07508735A (en) |
KR (1) | KR950702437A (en) |
AU (1) | AU671651B2 (en) |
BR (1) | BR9306700A (en) |
CA (1) | CA2139747A1 (en) |
CZ (1) | CZ3895A3 (en) |
DK (1) | DK89592D0 (en) |
FI (1) | FI950065A (en) |
HU (1) | HUT75665A (en) |
NZ (1) | NZ253678A (en) |
PL (1) | PL172724B1 (en) |
RU (1) | RU2139093C1 (en) |
SK (1) | SK1795A3 (en) |
WO (1) | WO1994001136A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0765173A1 (en) * | 1994-06-13 | 1997-04-02 | Garfield P. Royer | A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
WO1998000170A1 (en) * | 1996-07-01 | 1998-01-08 | Universiteit Utrecht | Hydrolysable hydrogels for controlled release |
US8026286B2 (en) | 1999-12-23 | 2011-09-27 | Bend Research, Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US10905765B2 (en) | 2011-12-05 | 2021-02-02 | Incept, Llc | Medical organogel processes and compositions |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2794958A1 (en) * | 2010-03-29 | 2011-10-06 | Surmodics, Inc. | Injectable drug delivery formulation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024073A (en) * | 1972-01-08 | 1977-05-17 | Toray Industries, Inc. | Hydrogel and production thereof |
GB2078110A (en) * | 1980-06-20 | 1982-01-06 | Crinos Industria Farmaco | Spermicidal contraceptives in a crosslinked dextran vehicle |
WO1992000732A1 (en) * | 1990-07-04 | 1992-01-23 | Kabi Pharmacia Ab | Therapeutical composition and process for its preparation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2550750A (en) * | 1947-09-22 | 1951-05-01 | Arthur C Abelt | Differential for automobiles |
JPS5997346A (en) * | 1982-11-24 | 1984-06-05 | Komatsu Ltd | Differential device of car |
-
1992
- 1992-07-07 DK DK92895A patent/DK89592D0/en not_active Application Discontinuation
-
1993
- 1993-07-06 PL PL93307050A patent/PL172724B1/en unknown
- 1993-07-06 KR KR1019950700048A patent/KR950702437A/en not_active Application Discontinuation
- 1993-07-06 JP JP6502843A patent/JPH07508735A/en not_active Expired - Lifetime
- 1993-07-06 SK SK17-95A patent/SK1795A3/en unknown
- 1993-07-06 CA CA002139747A patent/CA2139747A1/en not_active Abandoned
- 1993-07-06 CZ CZ9538A patent/CZ3895A3/en unknown
- 1993-07-06 HU HU9500042A patent/HUT75665A/en unknown
- 1993-07-06 NZ NZ253678A patent/NZ253678A/en unknown
- 1993-07-06 EP EP93914649A patent/EP0648129A1/en not_active Withdrawn
- 1993-07-06 RU RU95105519A patent/RU2139093C1/en active
- 1993-07-06 AU AU44178/93A patent/AU671651B2/en not_active Ceased
- 1993-07-06 WO PCT/DK1993/000227 patent/WO1994001136A1/en not_active Application Discontinuation
- 1993-07-06 BR BR9306700A patent/BR9306700A/en not_active Application Discontinuation
-
1995
- 1995-01-05 FI FI950065A patent/FI950065A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024073A (en) * | 1972-01-08 | 1977-05-17 | Toray Industries, Inc. | Hydrogel and production thereof |
GB2078110A (en) * | 1980-06-20 | 1982-01-06 | Crinos Industria Farmaco | Spermicidal contraceptives in a crosslinked dextran vehicle |
WO1992000732A1 (en) * | 1990-07-04 | 1992-01-23 | Kabi Pharmacia Ab | Therapeutical composition and process for its preparation |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0765173A1 (en) * | 1994-06-13 | 1997-04-02 | Garfield P. Royer | A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
EP0765173A4 (en) * | 1994-06-13 | 1998-09-23 | Garfield P Royer | A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
WO1998000170A1 (en) * | 1996-07-01 | 1998-01-08 | Universiteit Utrecht | Hydrolysable hydrogels for controlled release |
US6497903B1 (en) | 1996-07-01 | 2002-12-24 | Wilhelmus Everhardus Hennink | Hydrolysable hydrogels for controlled release |
US7060296B2 (en) | 1996-07-01 | 2006-06-13 | Universiteit Utrecht | Hydrolysable hydrogels for controlled release |
US8026286B2 (en) | 1999-12-23 | 2011-09-27 | Bend Research, Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US8501231B2 (en) | 1999-12-23 | 2013-08-06 | Bend Research, Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US8796341B2 (en) | 1999-12-23 | 2014-08-05 | Bend Research, Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US8980321B2 (en) | 1999-12-23 | 2015-03-17 | Bend Research, Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US9457095B2 (en) | 1999-12-23 | 2016-10-04 | Bend Research, Inc. | Pharmaceutical compositions providing enhanced drug concentrations |
US10905765B2 (en) | 2011-12-05 | 2021-02-02 | Incept, Llc | Medical organogel processes and compositions |
US11890343B2 (en) | 2011-12-05 | 2024-02-06 | Incept, Llc | Medical organogel processes and compositions |
Also Published As
Publication number | Publication date |
---|---|
BR9306700A (en) | 1998-12-08 |
FI950065A (en) | 1995-03-02 |
SK1795A3 (en) | 1995-09-13 |
DK89592D0 (en) | 1992-07-07 |
RU2139093C1 (en) | 1999-10-10 |
PL307050A1 (en) | 1995-05-02 |
CA2139747A1 (en) | 1994-01-20 |
AU4417893A (en) | 1994-01-31 |
HU9500042D0 (en) | 1995-03-28 |
CZ3895A3 (en) | 1995-09-13 |
NZ253678A (en) | 1996-07-26 |
EP0648129A1 (en) | 1995-04-19 |
AU671651B2 (en) | 1996-09-05 |
HUT75665A (en) | 1997-05-28 |
JPH07508735A (en) | 1995-09-28 |
KR950702437A (en) | 1995-07-29 |
PL172724B1 (en) | 1997-11-28 |
FI950065A0 (en) | 1995-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0502032B1 (en) | Delayed release formulations | |
JP4088420B2 (en) | Colon selective drug delivery composition and pharmaceutical preparation using polysaccharides | |
US6284273B1 (en) | Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds | |
US20030077326A1 (en) | Low temperature coatings | |
JP2001519379A (en) | Delayed total release gastrointestinal drug delivery system | |
JP2000507561A (en) | Pharmaceutical sustained-release tablets containing cross-linked amylose-based carrier and hydroxypropylmethylcellulose | |
HU210497B (en) | Process for production of modified pectin | |
CA2121038C (en) | Oral preparation for release in lower digestive tracts | |
JPH11506432A (en) | Bisacodyl dosage form for colon delivery | |
US20240082168A1 (en) | Controlled drug release formulation | |
JP2002505290A (en) | Pharmaceutical composition comprising cefuroxime acetyl that is stable against water absorption | |
AU671651B2 (en) | A drug delivery device and a method of making such device | |
US20110189242A1 (en) | Oral galenic form, polymer production method and use of same | |
Vibhooti et al. | Eudragit and chitosan—The two most promising polymers for colon drug delivery | |
Chaurasia et al. | Synthetic polymers as biomaterials for the treatment of colon diseases | |
EP1534246B1 (en) | Sustained release pharmaceutical composition of a cephalosporin antibiotic | |
CN112770730B (en) | Controlled drug release formulations | |
Iglesias Blanco et al. | In-Depth Study into Polymeric Materials in Low-Density Gastroretentive Formulations | |
Soni et al. | Polysaccharides for Bacterially Triggered System in Colon Targeting | |
Bhattacharjee | Colon-specific release of Metronidazole from tablets compression-coated | |
Soni et al. | Enzyme Specific Drug Delivery System: A Potential Approach for Colon Targeting | |
Kolhe | Synthesis and evaluation of polymers for novel drug delivery systems | |
Sowjanya | Formulation and In-Vitro Evaluation of Mebeverine Hydrochloride Colon Targeted Micropellets for The Treatment of Irritable Bowel Syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1795 Country of ref document: SK Ref document number: PV1995-38 Country of ref document: CZ Ref document number: 950065 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2139747 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993914649 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 253678 Country of ref document: NZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1993914649 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV1995-38 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993914649 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1995-38 Country of ref document: CZ |